✦ LIBER ✦

Potent Inhibitors of Lipoprotein-Associated Phospholipase A2: Benzaldehyde O-Heterocycle-4-carbonyloxime.

✍ Scribed by Hyung Jae Jeong; Yong-Dae Park; Ho-Yong Park; Il Yun Jeong; Tae-Sook Jeong; Woo Song Lee

Publisher: John Wiley and Sons
Year: 2007
Weight: 25 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200706088

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

ChemInform Abstract: Potent, Orally Acti

ChemInform Abstract: Potent, Orally Active Inhibitors of Lipoprotein-Associated Phospholipase A2: 1-(Biphenylmethylamidoalkyl)-pyrimidones.

✍ Stephen A. Smith; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

ChemInform Abstract: The Identification

ChemInform Abstract: The Identification of a Potent, Water Soluble Inhibitor of Lipoprotein-Associated Phospholipase A2.

✍ Stephen A. Smith; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 2 views

ChemInform Abstract: 2-(Alkylthio)pyrimi

ChemInform Abstract: 2-(Alkylthio)pyrimidin-4-ones as Novel, Reversible Inhibitors of Lipoprotein-Associated Phospholipase A2.

✍ Stephen A. Smith; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 1 views

The Identification of Clinical Candidate

The Identification of Clinical Candidate SB-480848 (I): A Potent Inhibitor of Lipoprotein-Associated Phospholipase A2.

✍ Stephen A. Smith; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 60 KB 👁 1 views

ChemInform Abstract: N-1 Substituted Pyr

ChemInform Abstract: N-1 Substituted Pyrimidin-4-ones: Novel, Orally Active Inhibitors of Lipoprotein-Associated Phospholipase A2.

✍ Stephen A. Smith; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 2 views

The Discovery of SB-435495: A Potent, Or

The Discovery of SB-435495: A Potent, Orally Active Inhibitor of Lipoprotein-Associated Phospholipase A2 for Evaluation in Man.

✍ Stephen A. Smith; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 66 KB 👁 1 views